Backed by Main Sequence & CSIRO

Pending AI

AI and quantum mechanics for drug discovery

Pending AI seamlessly integrates scalable quantum mechanics and artificial intelligence to unlock new drug discovery possibilities. Their platform enables well-established disease targets previously considered undruggable to be targeted with novel small molecules, ushering in a new paradigm of medicinal innovation.

Explore Pending AILearn More

Unlock Undruggable Targets

A comprehensive drug discovery platform powered by AI and quantum mechanics that designs higher-quality small-molecule medicines for previously intractable disease targets.

Fuses quantum mechanical simulation with AI to model molecular interactions at unprecedented accuracy

Unlocks disease targets previously considered undruggable with conventional computational approaches

Dual presence in Boston and Sydney connecting leading pharmaceutical and research ecosystems

Backed by Main Sequence & CSIRO

Ready to learn more about Pending AI?

Discover how Pending AI is transforming their industry with deep technology innovation.

Explore Pending AIView All Portfolio